Jim Simons's position in Entero Therapeutics is currently worth $502k. That's 0.00% of their equity portfolio (2432nd largest holding). The investor owns 1.42% of the outstanding Entero Therapeutics stock. The first Entero Therapeutics trade was made in Q3 2025. Since then Jim Simons bought shares one more times and sold shares on two occasions. The investor's estimated purchase price is $508k, resulting in a loss of 1.1%.